| 2024 |
Li, M., Bennett, M. K., Toubia, J., Pope, V. S., Tea, M. N., Tamang, S., . . . Pitson, S. M. (2024). An orthotopic syngeneic mouse model of bortezomib-resistant multiple myeloma. British Journal of Haematology, 204(2), 566-570.
DOI Scopus1 WoS1 Europe PMC1 |
| 2022 |
Anshabo, A. T., Bantie, L., Diab, S., Lenjisa, J., Kebede, A., Long, Y., . . . Wang, S. (2022). An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers, 14(5), 1113.
DOI Scopus12 WoS10 Europe PMC10 |
| 2022 |
Lewis, A. C., Pope, V. S., Tea, M. N., Li, M., Nwosu, G. O., Nguyen, T. M., . . . Pitson, S. M. (2022). Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia.. Blood, 139(26), 3737-3751.
DOI Scopus37 WoS32 Europe PMC35 |
| 2021 |
Yu, M., Teo, T., Yang, Y., Li, M., Long, Y., Philip, S., . . . Wang, S. (2021). Potent and orally bioavailable CDK8 inhibitors: design, synthesis, structure-activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry, 214, 1-22.
DOI Scopus14 WoS13 Europe PMC11 |
| 2021 |
Bennett, M. K., Li, M., Tea, M. N., Pitman, M. R., Toubia, J., Wang, P. P. -S., . . . Pitson, S. M. (2021). Resensitising proteasome inhibitor-resistant myeloma with sphingosine kinase 2 inhibition.. Neoplasia, 24(1), 1-11.
DOI Scopus16 WoS16 Europe PMC13 |
| 2021 |
Yu, M., Long, Y., Yang, Y., Li, M., Teo, T., Noll, B., . . . Wang, S. (2021). Discovery of a potent, highly selective, and orally bioavailable inhibitor of CDK8 through a structure-based optimisation. European Journal of Medicinal Chemistry, 218(113391), 23 pages.
DOI Scopus9 WoS8 Europe PMC8 |
| 2019 |
Khair, N. Z., Lenjisa, J. L., Tadesse, S., Kumarasiri, M., Basnet, S. K. C., Mekonnen, L. B., . . . Wang, S. (2019). Discovery of CDK5 inhibitors through structure-guided approach. ACS, 10(5), 786-791.
DOI Scopus23 WoS21 Europe PMC18 |
| 2019 |
Abdelaziz, A. M., Basnet, S. K. C., Islam, S., Li, M., Tadesse, S., Albrecht, H., . . . Wang, S. (2019). Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors. Bioorganic & medicinal chemistry letters, 29(18), 2650-2654.
DOI Scopus10 WoS10 Europe PMC7 |
| 2012 |
Chen, L., Liu, W. Q., Lei, J. H., Guan, F., Li, M., Song, W. J., . . . Wang, T. (2012). Chronic schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice. PLoS one, 7(12, article no. e51512), 1-7.
DOI |
| 2011 |
Li, J., Cao, J., Li, M., Yu, Y., Yang, Y., Xiao, X., . . . Chen, H. (2011). Collagen triple helix repeat containing-1 inhibits transforming growth factor-β1-induced collagen type I expression in keloid. British journal of dermatology, 164(5), 1030-1036.
DOI |
| 2011 |
Li, M. J., Lei, J. H., Wang, T., Lu, S. J., Guan, F., Liu, W. Q., & Li, Y. L. (2011). Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum. Experimental parasitology, 128(4), 427-432.
DOI |
| 2009 |
Lei, J. H., Liu, W. Q., Sun, C. S., Tang, C. L., Li, M. J., Chen, Y. L., & Li, Y. L. (2009). Detection of circulating antigen in serum of mice infected with Schistosoma japonicum by immunomagnetic bead ELISA based on IgY. Acta tropica, 111(1), 39-43.
DOI |
